Hikma Pharmaceuticals PLC (HIK.DI)

Also known as:  Hikma
Data delayed by 15 minutes
56.71 USD 0.000.00%
As of 20 NOV 2007 09:44 GMT|Nasdaq Dubai

Hikma Stock Price & Performance Powered By Knowledge Direct

Recommendation
-
Div Yield
0.882%
P/E (Last 12 Month)
0.0
Upside
-
Target Price (Mean)
-
52Wk
0.0
0.0

Open
Data not available
Previous Close
56.71 USD
Turnover
Data not available
EPS
1.31 USD
Volume
0
Transactions
0
Market Cap
13.09B USD
IPO Date
01-Nov-2005
Analyst Recommendation
Sell
Hold
Buy
Analyst Rating
Strong Buy
Buy
Hold
Sell
Strong Sell

About Hikma Pharmaceuticals PLCLast updated on: 30 December 2015

Business Summary
Manufacturing and distribution of generic, branded and licensed pharmaceuticals; manufacturing of cosmetics, skin care, veterinary and plastic packaging products; provides biotechnology research services; ownership and operation of pharmacies and drug stores.
Country of Incorporation
Ownership Type
Established In
1978
Primary Sector
Stock Listing
IDStock TypeCurrencyExchangeSymbol
HIK.DIFXOrdinaryUSDNasdaq DubaiHIK

Contact details

Primary address
Street: 13 Hanover Square
Area: Mayfair
P.O. Box: W1S 1HW
Country: United Kingdom
City: London
CONTACT
Region
London
More
All Press Releases

UAE and Israel to cooperate on healthcare services

The agreement would contribute to enhancing the protection of health data for patients and the exchange of research between the two countries: official

WAM (Emirates News Agency) - Thursday 22 April 2021
All Health Care News
All Markets News

Ownership

Revenue
Net Income
Profit Margin
Total Assets
Total Liabilities
Debt to Assets
Operating
Investing
Financing

Executives

Mr Sigurdur Olafsson
Chief Executive Officer
Mr Khaled Al Nabilsi
Chief Financial Officer
Mr Bassam Wael Rushdi Kanaan
Chief Strategy and Corporate Development Officer

Board Members

HE Said Samih Taleb Darwazeh
Chairman
HE Mazen Samih Taleb Darwazeh
Vice Chairman
Mr Mohammed Ali Khaldoun Satea Al Husry
Director
More

Company information provided by Refinitiv

Refinitiv research team update company information from primary sources (company annual reports, press releases, company websites, corporate briefings, official statements/interviews) and reliable secondary sources (stock markets, reliable third party publications).

More

Most Viewed Stocks

Stock Screener

More